Kidney Disease (Pediatric) Clinical Trials

A listing of Kidney Disease (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 258 clinical trials
Circulating Oxytocin Changes in Response to the Oxytocin System Stimulator MDMA in Patients With Diabetes Insipidus and Healthy Controls

This study is to evaluate oxytocin levels in response to MDMA administration as compared to placebo in patients with diabetes insipidus and healthy volunteers.

  • 0 views
  • 18 Feb, 2021
  • 1 location
Everolimus Monotherapy as Immunosuppression After Liver Transplant

Tacrolimus is the standard immunosuppressive drug used to prevent organ rejection post liver transplant. One side effect of Tacrolimus is nephrotoxicity. Everolimus does not have the nephrotoxicity side effects of Tacrolimus. Replacement of Tacrolimus by Everolimus may have a reduced incidence of renal dysfunction in liver transplant patients who have …

  • 0 views
  • 23 Jan, 2021
  • 1 location
Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)

Hepatorenal syndrome-acute kidney injury (HRS-AKI), a potentially reversible renal failure, is a serious, rapidly progressing, often fatal, complication of decompensated cirrhosis. Terlipressin is a synthetic vasopressin analogue that acts as a systemic vasoconstrictor via the vascular vasopressin V1 receptors. In HRS-AKI patients the strong V1 receptor-mediated vasoconstrictor activity of terlipressin, …

angiotensin
aldosterone
ascites
renal failure
  • 0 views
  • 21 Aug, 2021
  • 6 locations
Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy

This clinical trial assessed the safety of human umbilical cord mesenchymal stem cell therapy in 15 patients with diabetic nephropathy. Fifteen subjects received umbilical cord mesenchymal stem cell therapy 3 times. Approximately 1 106/kg of human umbilical cord mesenchymal stem cells were administered by peripheral intravenous infusion once a month …

  • 0 views
  • 01 May, 2021
  • 1 location
Comparison of Efficacy of Intercostal Nerve Block vs Peritract Infiltration With 0.25% Bupivacaine in PCNL

Percutaneous nephrolithotomy (PCNL) is the preferred treatment for renal stones >2 cm or resistant to ESWL. Postoperative pain following this invasive surgery adds to the morbidity of patient which requires additional analgesia and can affect the quality of care. To lower the morbidity of PCNL, proper and adequate management of …

  • 0 views
  • 16 Apr, 2021
  • 1 location
Lanthanum Carbonate (Fosrenol ) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis

This study investigates the efficacy and the safety of Lanthanum Carbonate for the reduction of urinary oxalate excretion in patients with secondary hyperoxaluria and nephrolithiasis.

hyperoxaluria
oxalate
  • 0 views
  • 28 Jan, 2021
  • 1 location
Measurement of Renal Functional Reserve

Single arm physiological study to measure renal functional reserve as a biomarker of kidney function and health

glomerular filtration rate
  • 12 views
  • 22 Jan, 2021
Ultrasound Imaging of Kidney Stones and Lithotripsy

The purpose of this study is to determine whether new software processing of ultrasound images can improve detection and size determination of kidney stones.

calcium
imaging of kidney
lithotripsy
ct scan
nephrolithiasis
  • 83 views
  • 26 Jan, 2021
  • 1 location
NSAIDs Stent Study

This is a pilot study to (1) evaluate the effect of Ketorolac on inflammatory response and its impact on stent related symptoms in patients undergoing stent placement procedure and (2) assess feasibility of recruitment, randomization, assessment procedures and implementation of the study intervention.

stent placement
urolithiasis
ketorolac
  • 25 views
  • 28 May, 2021
  • 1 location
Multiple Doses of DM199 in Patients With Chronic Kidney Disease

An open-label, Phase II, multi-center study evaluating multiple doses of DM199 in participants with chronic kidney disease.

hemoglobin a1c
hypertension
renal impairment
diabetes
glycated hemoglobin
  • 125 views
  • 28 Aug, 2021
  • 16 locations